SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Versicor (VERS)
An SI Board Since August 2000
Posts SubjectMarks Bans Symbol
83 9 0 MICU
Emcee:  sim1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
33Merger is final....now VERS has three drugs in Phase III trials... biz.yahoo.coArthur Radley-3/3/2003
32Merger effective as of tomorrow...one would have to admit that they will have a Arthur Radley-2/28/2003
314th Q and full year financials released this morning. Very positive update for aArthur Radley-2/28/2003
30One can only hope that they are right on VERS.. biz.yahoo.comArthur Radley-2/25/2003
29Appears that VERS has a lot on its plate in the near future. This upcoming confeArthur Radley-2/23/2003
28Final merger should be announced this week. Q results within next few days. PhasArthur Radley-2/23/2003
27Look at the closing activity today...kabooom! host.businessweek.comArthur Radley-1/31/2003
26For anyone that wasn't paying attention today...VERS had traded 40,000 shareArthur Radley-1/31/2003
25This one has been a little sleeper stock for me, but it has come alive over the Arthur Radley-1/15/2003
24From medline: ..."In January 2002, UBS Warburg predicted filing of an NDA iCacaito-1/15/2003
23Td, seems a very neat drug that could decrease complications, hospitalizations dCacaito-1/15/2003
22Excellent news this morning from VERS....Arthur Radley-1/6/2003
21FREMONT, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Versicor Inc. (Nasdaq: VERS -nigel bates-12/17/2002
20FREMONT, Calif., Sept. 5 /PRNewswire-FirstCall/ -- Versicor Inc. (Nasdaq: VERS -nigel bates-9/5/2002
19FREMONT, Calif., June 26 /PRNewswire/ -- Versicor, Inc. (Nasdaq: VERS - news) tonigel bates-6/26/2001
18GERENZANO, Italy, May 22 /PRNewswire/ -- Biosearch Italia S.p.A. (Nuovo Mercato:nigel bates-5/22/2001
17FREMONT, Calif., March 22 /PRNewswire/ -- Versicor, Inc. (Nasdaq: VERS - news) tnigel bates-3/22/2001
16Agreement With Pharmacia to Expedite Discovery Of Novel Oxazolidinones FREMONT, olivier benrubi-1/3/2001
15Dec. 4 /PRNewswire/ -- Versicor, Inc. (Nasdaq: VERS - news) and Biosearch Italianigel bates-12/7/2000
14Versicor Achieves Second Milestone From Novartis Collaboration FREMONT, Calif., olivier benrubi-11/15/2000
13Sept. 18 /PRNewswire/ -- Versicor, Inc. (Nasdaq: VERS - news) today announced prnigel bates-9/18/2000
12Sept. 18 /PRNewswire/ -- Versicor, Inc. (Nasdaq: VERS - news) will report substanigel bates-9/18/2000
11$44 per share in cash and only a $13 stock?!!!! Seems like they are well funded,jfoley-9/4/2000
10Combinatorial Lead Development of Oxazolidinones: Synthesis and Antimicrobial Acsim1-8/19/2000
9Combinatorial Lead Development of Oxazolidinones: Synthesis and In Vitro Activitsim1-8/19/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News